Tech trio aims to help breast cancer survivors remember daily pills
NCT ID NCT06865755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a system combining a smartphone app, a special pill bottle that records when it's opened, and a Fitbit can help breast cancer survivors take their long-term hormone therapy more consistently. Fifteen survivors aged 21-70 will use the system for six months and share their experiences through surveys. The goal is to see if this technology makes it easier to stick to the daily medication routine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
San Diego State University
San Diego, California, 92120, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Exercise during chemo: a new weapon to preserve strength?
- Could a smartphone program ease Chemo's emotional toll?
- Could fewer heart tests be safer for breast cancer patients?
- New online group therapy aims to clear chemo brain in breast cancer survivors
- New study aims to predict who will respond to breast cancer therapy
- Fasting at night may boost brain power for breast cancer survivors